Log in

High-dose planned adaptive helical tomotherapy for cutaneous angiosarcoma of the scalp

  • Original Article
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to investigate the feasibility and effectiveness of high-dose planned adaptive intensity-modulated radiation therapy (IMRT) with helical tomotherapy (HT) for cutaneous angiosarcoma (cAS) of the scalp.

Methods

This retrospective cross-sectional included a total of 12 consecutive patients with cAS of the scalp who underwent high-dose planned adaptive IMRT with HT. Prescribed doses were 72.5–74 Gy in 35–37 fractions for the gross tumor volume plus a 1–2 mm margin (PTV1), 58–60 Gy in 29–30 fractions for the clinical target volume plus a 2–3 mm margin (PTV2), and 46 Gy in 23 fractions for the clinical target volume plus a 5–15 mm margin (PTV3) over periods of 7.5, 6 and 4.5 weeks, respectively.

Results

The estimated 1‑year and 2‑year overall survival rate were 65.6% and 27.3%, respectively, and the local progression-free survival at 2 years was 74.1%. All local recurrences were either in or marginal to the PTV2 or PTV3. No local recurrence was observed in the PTV1. All patients tolerated the treatment without grade 3 or higher adverse events during the radiotherapy period. No late adverse events were observed during the follow-up period.

Conclusion

Planned adaptive high-dose IMRT with HT has the potential to improve local control rate without increasing adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ishida Y, Otsuka A, Kabashima K (2018) Cutaneous angiosarcoma: update on biology and latest treatment. Curr Opin Oncol 30:107–112. https://doi.org/10.1097/CCO.0000000000000427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Katano A, Yamashita H, Nakagawa K (2021) Radical radiotherapy for localized cutaneous angiosarcoma of the scalp. Mol Clin Oncol 15:195. https://doi.org/10.3892/mco.2021.2357

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hata M, Wada H, Ogino I, Omura M, Koike I, Tayama Y et al (2014) Radiation therapy for angiosarcoma of the scalp: treatment outcomes of total scalp irradiation with X‑rays and electrons. Strahlenther Onkol 190:899–904. https://doi.org/10.1007/s00066-014-0627-z

    Article  PubMed  Google Scholar 

  4. Miki Y, Tada T, Kamo R, Hosono MN, Tamiya H, Shimatani Y et al (2013) Single institutional experience of the treatment of angiosarcoma of the face and scalp. Br J Radiol 86:20130439. https://doi.org/10.1259/bjr.20130439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S et al (2012) Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients. Br J Radiol 85:e1127–33. https://doi.org/10.1259/bjr/31655219

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S et al (2015) Angiosarcoma of the scalp and face: the Mayo Clinic experience. JAMA Otolaryngol Head Neck Surg 141:335–340. https://doi.org/10.1001/jamaoto.2014.3584

    Article  PubMed  Google Scholar 

  7. Hata M (2018) Radiation therapy for angiosarcoma of the scalp: Total scalp irradiation and local irradiation. Anticancer Res 38:1247–1253. https://doi.org/10.21873/anticanres.12346

    Article  PubMed  Google Scholar 

  8. Cao J, Wang J, He C, Fang M (2019) Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res 29:2303–2313

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Yukihiro Hama, Toshiro Tsukamoto and Etsuko Tate. The first draft of the manuscript was written by Yukihiro Hama and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yukihiro Hama M.D., Ph.D..

Ethics declarations

Conflict of interest

Y. Hama, T. Tsukamoto and E. Tate declare that they have no competing interests.

Ethical standards

Approval was obtained from the ethics committee of Edogawa Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hama, Y., Tsukamoto, T. & Tate, E. High-dose planned adaptive helical tomotherapy for cutaneous angiosarcoma of the scalp. Strahlenther Onkol 200, 123–127 (2024). https://doi.org/10.1007/s00066-023-02093-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-023-02093-7

Keywords

Navigation